Prevnar 20 Archives -

Dominance of the pneumococcal vaccine category is a race between Merck & Co and Pfizer, and while the

Merck ups the stakes in pneumococcal jab face-off with Pfizer

https://pharmaphorum.com/news/merck-ups-the-stakes-in-pneumococcal-jab-face-off-with-pfizer/

Pfizer’s new Prevnar 20 conjugate pneumococcal vaccine can be dosed at the same time as the seasonal flu

Pfizer ups pressure on Merck with Prevnar, flu vaccine co-dosing study

https://pharmaphorum.com/news/pfizer-ups-pressure-on-merck-with-prevnar-flu-vaccine-co-dosing-study/

Just a month after getting approval for its new pneumococcal vaccine Vaxneuvance in adults, Merck & Co has

Merck & Co raises pressure on Pfizer in pneumococcal vaccine tussle

https://pharmaphorum.com/news/merck-raises-pressure-on-pfizer-in-pneumococcal-vaccine-tussle/

The FDA has approved a new pneumococcal vaccine from Merck & Co, just over a month after Pfizer

FDA okays Merck’s would-be Prevnar rival Vaxneuvance

https://pharmaphorum.com/news/fda-okays-mercks-would-be-prevnar-rival-vaxneuvance/

Already facing one rival to its blockbuster pneumococcal vaccine Prevnar, Pfizer could have another to contend with, after

Shot in the arm for Affinivax as it challenges Pfizer’s Prevnar

https://pharmaphorum.com/news/shot-in-the-arm-for-affinivax-as-it-challenges-pfizers-prevnar/

Pfizer has the FDA approval it was seeking for Prevnar 20, the latest update to its blockbuster pneumococcal

FDA clears Pfizer’s Prevnar 20 for adults, as Merck rival nears decision

https://pharmaphorum.com/news/fda-clears-pfizers-prevnar-20-for-adults-as-merck-rival-nears-decision/

Prevnar 20